The National Health Service (NHS) joint venture (JV) Medtech Accelerator has awarded approximately £500k funding for new medical technology projects in the UK.
Grants between £80,000 and £125,000 each have been made to support development of a safe regional anaesthesia injection system, vacuum therapy for upper gastrointestinal (UGI) tract leaks, a non-invasive diagnostic device for sleep apnoea, and a technology to improve tissue ablation efficacy to destroy tumours.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Medtech Accelerator is a JV between the NHS and regional business partners such as Health Enterprise East (HEE), New Anglia and Greater Cambridge Greater Peterborough (GCGP) Local Enterprise Partnerships (LEPs) and the Eastern Academic Health Science Network (AHSN).
It has been set up to offer funding for early stage development of new medical technologies.
In addition to development of prototypes, the latest grants will be utilised for further technological support, preparing for CE-Mark and conducting clinical trials in humans.
Health Enterprise East CEO Dr Anne Blackwood said: “We are delighted to issue our second round of awards, which when combined with our first round of awards launched earlier this year totals £670k for seven projects – all of which have the potential to become game-changers in the NHS and life-changing for patients.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe new Safer Injection System for Regional Anaesthesia (SAFIRA) will be developed by Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust and development partner, 42 Technology.
Cambridge University Hospitals NHS Foundation Trust and JEB Technologies are set to develop the endoluminal vacuum device (E-Vac), while Papworth Hospital NHS Foundation Trust and Iceni Labs will develop the non-contact sleep apnoea measurement device.
The new Bimodal Electric Tissue Ablation (BETA) method will be handled by Norfolk and Norwich University Hospital NHS Foundation Trust (NNUH) spin out, Ablatus Therapeutics.
